histamine has been researched along with Osteoarthritis in 19 studies
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diacerein (DCN), an analogue of rhein (a glycosidal compound of natural origin), is currently used in the treatment of osteoarthritis and is given a fast-track designation for development to treat epidermolysis bullosa (EB)." | 9.22 | Therapeutic Potential of Diacerein in Management of Pain. ( Jain, M; Joharapurkar, A; Patel, V, 2022) |
| "Intrathecally injected histamine increased incapacitation and articular edema, whereas the H1R antagonist, cetirizine, decreased both parameters." | 7.83 | Histaminergic Pharmacology Modulates the Analgesic and Antiedematogenic Effects of Spinally Injected Morphine. ( Eto, C; Fin, FE; Mascarin, L; Souza-Silva, E; Stein, T; Tonussi, CR, 2016) |
| "The concentrations of insulin, C-peptide, prolactin, growth hormone, free triiodothyronine (FT3), thyrotropin (TSH), and histamine were determined in synovial fluid and plasma of 27 patients with rheumatoid arthritis (RA) and in 12 patients with osteoarthrosis (OA)." | 7.73 | Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis. ( Greguska, O; Imrich, R; Macho, L; Radikova, Z; Rovensky, J; Simorova, E; Vigas, M, 2005) |
| "Diacerein (DCN), an analogue of rhein (a glycosidal compound of natural origin), is currently used in the treatment of osteoarthritis and is given a fast-track designation for development to treat epidermolysis bullosa (EB)." | 5.22 | Therapeutic Potential of Diacerein in Management of Pain. ( Jain, M; Joharapurkar, A; Patel, V, 2022) |
| "Intrathecally injected histamine increased incapacitation and articular edema, whereas the H1R antagonist, cetirizine, decreased both parameters." | 3.83 | Histaminergic Pharmacology Modulates the Analgesic and Antiedematogenic Effects of Spinally Injected Morphine. ( Eto, C; Fin, FE; Mascarin, L; Souza-Silva, E; Stein, T; Tonussi, CR, 2016) |
| "The concentrations of insulin, C-peptide, prolactin, growth hormone, free triiodothyronine (FT3), thyrotropin (TSH), and histamine were determined in synovial fluid and plasma of 27 patients with rheumatoid arthritis (RA) and in 12 patients with osteoarthrosis (OA)." | 3.73 | Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis. ( Greguska, O; Imrich, R; Macho, L; Radikova, Z; Rovensky, J; Simorova, E; Vigas, M, 2005) |
| "In order to address the issue of the role of mast cells (MC) and nitric oxide (NO) in rheumatic synovial-fluid diseases, synovial fluid (SF) collected from the knee of patients with osteoarthritis (OA), articular chondrocalcinosis (ACC) or rheumatoid arthritis (RA) was examined for the levels of mast cells (MC), histamine, tryptase, phospholipase A2 and nitrite." | 3.69 | Cellular activation products in osteoarthritis synovial fluid. ( Florentin, J; Galoppin, L; Hilliquin, P; Menkes, CJ; Renoux, M, 1995) |
| "Histamine effects were analysed with the histamine H(1) and H(2) receptor antagonists, mepyramine and ranitidine, respectively." | 1.32 | Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage. ( Tetlow, LC; Woolley, DE, 2003) |
| "Histamine levels have been measured in plasma and synovial fluid (SF) obtained from patients with various arthritides, using a radioenzymatic assay procedure." | 1.27 | Histamine levels in human synovial fluid. ( Cleland, LG; Frewin, DB; Jonsson, JR; Robertson, PW, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, X | 1 |
| Younis, S | 1 |
| Shi, H | 1 |
| Hu, S | 1 |
| Zia, A | 1 |
| Wong, HH | 1 |
| Elliott, EE | 1 |
| Chang, T | 1 |
| Bloom, MS | 1 |
| Zhang, W | 1 |
| Liu, X | 1 |
| Lanz, TV | 1 |
| Sharpe, O | 1 |
| Love, ZZ | 1 |
| Wang, Q | 1 |
| Robinson, WH | 1 |
| Patel, V | 1 |
| Joharapurkar, A | 1 |
| Jain, M | 1 |
| Chen, C | 1 |
| Xie, J | 1 |
| Rajappa, R | 1 |
| Deng, L | 1 |
| Fredberg, J | 1 |
| Yang, L | 1 |
| Stein, T | 1 |
| Souza-Silva, E | 1 |
| Mascarin, L | 1 |
| Eto, C | 1 |
| Fin, FE | 1 |
| Tonussi, CR | 1 |
| Wojtecka-Lukasik, E | 1 |
| Ksiezopolska-Orlowska, K | 1 |
| Gaszewska, E | 1 |
| Krasowicz-Towalska, O | 1 |
| Rzodkiewicz, P | 1 |
| Maslinska, D | 1 |
| Szukiewicz, D | 1 |
| Maslinski, S | 1 |
| Tetlow, LC | 2 |
| Woolley, DE | 2 |
| SEIFERT, E | 1 |
| PERLSTEIN, IB | 1 |
| SHANSON, B | 1 |
| Rovensky, J | 1 |
| Imrich, R | 1 |
| Radikova, Z | 1 |
| Simorova, E | 1 |
| Greguska, O | 1 |
| Vigas, M | 1 |
| Macho, L | 1 |
| Renoux, M | 1 |
| Hilliquin, P | 1 |
| Galoppin, L | 1 |
| Florentin, J | 1 |
| Menkes, CJ | 1 |
| Buckley, MG | 1 |
| Walters, C | 1 |
| Wong, WM | 1 |
| Cawley, MI | 1 |
| Ren, S | 1 |
| Schwartz, LB | 1 |
| Walls, AF | 1 |
| Galletti, R | 1 |
| Duranti, R | 1 |
| Carnevalini, A | 1 |
| Bridges, AJ | 1 |
| Malone, DG | 1 |
| Jicinsky, J | 1 |
| Chen, M | 1 |
| Ory, P | 1 |
| Engber, W | 1 |
| Graziano, FM | 1 |
| Gruber, B | 1 |
| Poznansky, M | 1 |
| Boss, E | 1 |
| Partin, J | 1 |
| Gorevic, P | 1 |
| Kaplan, AP | 1 |
| Frewin, DB | 1 |
| Cleland, LG | 1 |
| Jonsson, JR | 1 |
| Robertson, PW | 1 |
| Nilsson, G | 1 |
| Persson, L | 1 |
| Winship, DH | 1 |
| Bernhard, GC | 1 |
1 review available for histamine and Osteoarthritis
| Article | Year |
|---|---|
Therapeutic Potential of Diacerein in Management of Pain.
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cytokines; Glutamates; Histam | 2022 |
18 other studies available for histamine and Osteoarthritis
| Article | Year |
|---|---|
RNA-seq characterization of histamine-releasing mast cells as potential therapeutic target of osteoarthritis.
Topics: Animals; Arthritis, Rheumatoid; Cetirizine; Histamine; Humans; Interleukin-1 Receptor-Like 1 Protein | 2022 |
Interleukin-1β and tumor necrosis factor-α increase stiffness and impair contractile function of articular chondrocytes.
Topics: Actins; Animals; Chondrocytes; Cytokines; Cytoskeleton; Elasticity; Extracellular Matrix; Goats; His | 2015 |
Histaminergic Pharmacology Modulates the Analgesic and Antiedematogenic Effects of Spinally Injected Morphine.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Carrageenan; Cetirizine; Disease Models, Anim | 2016 |
Cryotherapy decreases histamine levels in the blood of patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; beta-N-Acetylhexosaminidases; Cartilage; Cryotherapy; Enzyme-Linked Immunosor | 2010 |
Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage.
Topics: Cartilage, Articular; Cell Division; Chondrocytes; Histamine; Humans; Immunohistochemistry; Osteoart | 2003 |
[Osteoarthritis].
Topics: Histamine; Osteoarthritis; Radiotherapy | 1953 |
Histamine as a stress-combating agent in the treatment of rheumatic disease.
Topics: Arthritis; Arthritis, Rheumatoid; Histamine; Humans; Osteoarthritis; Rheumatic Diseases | 1955 |
Antistin and histamine in arthritis.
Topics: Arthritis; Arthritis, Rheumatoid; Hip; Histamine; Histamine Antagonists; Humans; Osteoarthritis | 1950 |
Immunolocalisation of histamine and histidine decarboxylase in chondrocytes of arthritic cartilage.
Topics: Cartilage; Chondrocytes; Histamine; Histidine Decarboxylase; Humans; Immunohistochemistry; Osteoarth | 2004 |
Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
Topics: Arthritis, Rheumatoid; C-Peptide; Female; Histamine; Human Growth Hormone; Humans; Insulin; Knee Joi | 2005 |
Cellular activation products in osteoarthritis synovial fluid.
Topics: Aged; Arthritis, Rheumatoid; Cell Count; Chondrocalcinosis; Chymases; Female; Histamine; Humans; Inf | 1995 |
Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid.
Topics: Adult; Aged; Aged, 80 and over; Arthritis; Arthritis, Rheumatoid; Chymases; Female; Histamine; Human | 1997 |
[Cephalgia due to cervical arthrosis. Physiopathological aspects].
Topics: Adult; Bradykinin; Cervical Vertebrae; Evoked Potentials; Female; Headache; Histamine; Humans; Kinin | 1975 |
Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1991 |
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.
Topics: Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Calcimycin; Fluorescent Antibody Technique; Hista | 1986 |
Histamine levels in human synovial fluid.
Topics: Arthritis; Arthritis, Rheumatoid; Histamine; Humans; Osteoarthritis; Psoriasis; Synovial Fluid | 1986 |
Changes in the synovial fluid of equine fetlock joints with lesions in the cartilage and joint capsule. A study in the standardbred horse.
Topics: Albumins; Animals; Cartilage, Articular; Forelimb; Globulins; Hindlimb; Histamine; Hoof and Claw; Ho | 1973 |
Basal and histamine-stimulated human gastric acid secretion. Lack of effect of indomethacin in therapeutic doses.
Topics: Adult; Aged; Arthritis, Reactive; Arthritis, Rheumatoid; Basal Metabolism; Female; Gastric Acidity D | 1970 |